Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

196 ARTÍCULOS , VIENDO DEL 1 AL 15

Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

Shi Y, Gu L, Wang Q, Gao L, Zhu J, Lu X, Zhou F, Zhu D, Zhang H, Xie C, Zhang Z.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):664-670. doi: 10.1093/gerona/glz005.

The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):47-53. doi: 10.1097/WAD.0000000000000342.

Update on posterior cortical atrophy

Holden SK, Bettcher BM, Pelak VS.

Curr Opin Neurol. 2020 Feb;33(1):68-73. doi: 10.1097/WCO.0000000000000767.

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial

Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.

JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.

Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease

Cantero JL, Atienza M, Lage C, Zaborszky L, Vilaplana E, Lopez-Garcia S, Pozueta A, Rodriguez-Rodriguez E, Blesa R, Alcolea D, Lleo A, Sanchez-Juan P, Fortea J; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224.

Current opinion neurology: visual pathway biomarkers in Alzheimer's disease

Van Stavern GP.

Curr Opin Neurol. 2020 Feb;33(1):79-86. doi: 10.1097/WCO.0000000000000788.

Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice

Shaw LM, Korecka M, Figurski M, Toledo J, Irwin D, Hee Kang J, Trojanowski JQ.

J Appl Lab Med. 2020 Jan 1;5(1):183-193. doi: 10.1373/jalm.2019.029587.

Role of Post-translational Modifications in Alzheimer's Disease

Ramesh M, Gopinath P, Govindaraju T.

Chembiochem. 2020 Apr 17;21(8):1052-1079. doi: 10.1002/cbic.201900573. Epub 2020 Jan 30.

Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review

Park JC, Han SH, Mook-Jung I.

BMB Rep. 2020 Jan;53(1):10-19. doi: 10.5483/BMBRep.2020.53.1.309.

Developing robust biomarkers for vascular cognitive disorders: adding 'V' to the AT(N) research framework

Sachdev PS.

Curr Opin Psychiatry. 2020 Mar;33(2):148-155. doi: 10.1097/YCO.0000000000000577.

[Current Clinical Trials in the Treatment of Alzheimer's Disease]

Tamaoka A.

Brain Nerve. 2020 Jan;72(1):23-34. doi: 10.11477/mf.1416201475.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias